Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: “Care Anywhere, Anytime”-Reference-Cited by-同舟云学术

Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: “Care Anywhere, Anytime”

Published:2022-12-28 Issue:1 Volume:24 Page:1-11
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Hui David^ORCID,Paiva Bianca Sakamoto Ribeiro,Paiva Carlos Eduardo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11864-022-01044-1.pdf

Reference44 articles.

1. Saunders C. The evolution of palliative care. J R Soc Med. 2001;94:430–2.

2. Mount BM. The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution. Can Med Assoc J. 1976;115:119–21.

3. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine. 2010;363:733–42.

4. Dalal S, Palla S, Hui D, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. The Oncologist. 2011;16:105–11.

5. Hui D, Cherny N, Latino N, Strasser F. The ‘'critical mass’' survey of palliative care programme at ESMO designated centres of integrated oncology and palliative care. Ann Oncol. 2017;28:2057–66.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of remote home care: assessment guided by the RE-AIM framework;BMC Health Services Research;2024-01-29

2. Effects of early exposure to palliative care on end-of-life outcomes in patients with cancer in a community setting;BMJ Supportive & Palliative Care;2023-12-09

3. Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy;Cancers;2023-08-15

4. Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma;Cancers;2023-08-11

5. Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment;Healthcare;2023-08-07